All In Biotech

Free tool

FAERS Monitor: Solosec

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 209363 or its brand name (Solosec, Secnidazole). Reports on generic versions are filed under their own applications.

Reports

282

Serious

66

23% of reports

Hospitalization

22

Death reported

3

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • vomiting78
  • nausea51
  • drug ineffective31
  • diarrhoea23
  • wrong technique in product usage process22
  • product taste abnormal21
  • headache20
  • dysgeusia18
  • abdominal pain17
  • malaise13
  • no adverse event13
  • abdominal discomfort11
  • chromaturia11
  • bacterial vaginosis10
  • foetal exposure during pregnancy10

Reports by year received

View as table
YearReports
20061
20081
20102
20111
20122
20133
20161
201854
2019108
202064
202116
202210
202311
20243
20254
20261

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,877 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
bacterial vaginosisSignal10480.1260.74,287
product taste abnormalSignal21115.976.72,276
chromaturiaSignal1136.420.4344
dysgeusiaSignal1818.111.6274
vomitingSignal7812.410.2822
foetal exposure during pregnancySignal109.25.065
wrong technique in product usage processSignal228.15.4131
abdominal painSignal175.53.458
no adverse eventSignal135.43.142
abdominal discomfortSignal114.92.731
nauseaSignal514.83.7156
diarrhoeaSignal232.71.823
headacheSignal202.41.615
malaiseSignal132.21.38
drug ineffective311.81.310

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.